-
Greenphire Forms Strategic Partnership With Lazarex Cancer Foundation
Clinical Research News Brief | Greenphire recently announced that it has formed a partnership with the Lazarex Cancer Foundation, which will implement Greenphire's ClinCard participant reimbursement technology to remove financial burdens for the oncology patients it supports across the United States.
Jun 11, 2019
-
CRF Bracket Relaunches As Signant Health
Clinical Research News | CRF Bracket announced a new name and brand today. The company will now be known as Signant Health, a name more indicative of the kind of business the company is trying to build.
Jun 10, 2019
-
Why Pfizer Didn't Report Its Rheumatoid Arthritis Medication Might Prevent Alzheimer's
The Washington Post | A team of researchers inside Pfizer found the company's blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer's disease by 64%. However, Pfizer opted against further investigation and chose not to make the data public, the company confirmed.
Jun 5, 2019
-
Finding The Sweet Spot: Why Industry, Nonprofits Should (Or Can) Collaborate On Master Protocols
Clinical Research News Contributed Commentary | Healthcare research often gets caught up in conflicting priorities among drug makers, research institutions, patient organizations, and regulators—and nowhere is this more prevalent than in clinical research.
Jun 4, 2019
-
Caris, ICON, Parexel, And More: News From May 2019
Clinical Research News | May was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Caris, ICON, Parexel, and more.
May 30, 2019
-
Right Technology And Touch Needed In Early Clinical Development
Clinical Research News | In many respects, High Point Clinical Trials Center (HPCTC) is not your run-of-the-mill phase I study site.
May 29, 2019
-
RX In Chains: Transform Drug Adherence, Combat Counterfeits With Blockchain
Clinical Research News Contributed Commentary | Up to 1 million deaths are attributed to counterfeit prescriptions annually. Blockchain presents the opportunity to mitigate the counterfeit drug trade, yet the technology has implications beyond the problem.
May 24, 2019
